pillbase.ru

Hemlibra

Active substance: emicizumab

emicizumab

Centralised EU authorisationActive

Marketing holder: Roche Registration Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 6
  • Hemlibra
    INJECTION, SOLUTION · EMICIZUMAB 150 mg/mL
    50242-923
    Genentech, Inc.
  • Hemlibra
    INJECTION, SOLUTION · EMICIZUMAB 300 mg/2mL
    50242-930
    Genentech, Inc.
  • Hemlibra
    INJECTION, SOLUTION · EMICIZUMAB 105 mg/.7mL
    50242-922
    Genentech, Inc.
  • Hemlibra
    INJECTION, SOLUTION · EMICIZUMAB 30 mg/mL
    50242-920
    Genentech, Inc.
  • Hemlibra
    INJECTION, SOLUTION · EMICIZUMAB 60 mg/.4mL
    50242-921
    Genentech, Inc.
All products in this country (6)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-6ad0-7618-a507-67d572b247d1,01a1208c-6ad2-73b8-8f08-0c37f3dc9ded,01a12091-b67b-7804-9889-9c48ea153690,01a12093-93c7-7c79-a827-b5d7768f6f11,01a1209d-6da5-74ef-a26e-e2ee84cb522d;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004406
Registration status
Active
ATC code
B02BX06
Sources
  • product · EMA · EMEA/H/C/004406 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004406 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004406 · Verified 2026-10-09